ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Wasting phenotype for differentiating spinal tuberculosis from spinal pyogenic infection.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spinal infections.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSpinal tuberculosis (STB) and pyogenic spinal infection (PSI) often present with overlapping clinical manifestations and imaging features, leading to delayed diagnosis and suboptimal outcomes. Identifying reliable laboratory-based markers may improve early differential diagnosis. PURPOSES: To investigate wasting phenotype-related clinical and laboratory indicators for differentiating STB from PSI and to establish a clinically applicable diagnostic model.
methodsIn this prospective study, 253 patients with confirmed spinal infections were enrolled, including 159 with STB (62.85%) and 94 with PSI (37.15%). Demographic, clinical, and routine laboratory data were collected. Eight candidate metabolic and inflammatory variables were assessed using univariate analyses and multivariable logistic regression. Model performance was evaluated by receiver operating characteristic (ROC) analysis, calibration testing, and Youden-derived optimal thresholds.
resultsThree key variables-body temperature, high-density lipoprotein (HDL), and blood glucose-were independently associated with STB. In the adjusted model, each 1 °C increase in temperature reduced the odds of STB by approximately 69% (OR = 0.318; 95% CI: 0.138-0.731; P = 0.009), each 1 mmol/L increase in HDL increased the odds by 3.7-fold (OR = 3.692; 95% CI: 1.311-10.394; P = 0.011), and each 1 mmol/L increase in blood glucose reduced the odds by 24% (OR = 0.764; 95% CI: 0.622-0.938; P = 0.014). The model demonstrated moderate discrimination (AUC = 0.673, 95% CI: 0.604-0.740) but good calibration (P = 0.609). ROC-derived optimal thresholds were T ≤ 36.7 °C, HDL ≥ 0.89 mmol/L, and blood glucose ≤ 5.85 mmol/L, providing practical reference points for clinical application.
conclusionA composite wasting phenotype defined by lower body temperature, lower blood glucose, and elevated HDL significantly improves early differentiation of STB from PSI. While individual thresholds show limited standalone diagnostic value, the combined model provides a biologically plausible, interpretable, and clinically useful tool to aid decision-making in managing spinal infections. LEVELS OF EVIDENCE: Level 3 (According to the Oxford CEBM 2016 criteria for diagnostic studies).
Indexed as
Identifiers
41057595What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.